| Host inflammatory response to mosquito bites enhances the severity of arbovirus infection M Pingen, SR Bryden, E Pondeville, E Schnettler, A Kohl, A Merits, ... Immunity 44 (6), 1455-1469, 2016 | 107 | 2016 |
| Evolutionary pathways of transmitted drug-resistant HIV-1 M Pingen, M Nijhuis, JA de Bruijn, CAB Boucher, AMJ Wensing Journal of antimicrobial chemotherapy 66 (7), 1467-1480, 2011 | 78 | 2011 |
| Mosquito biting modulates skin response to virus infection M Pingen, MA Schmid, E Harris, CS McKimmie Trends in parasitology 33 (8), 645-657, 2017 | 43 | 2017 |
| Defining the chemokine basis for leukocyte recruitment during viral encephalitis D Michlmayr, CS McKimmie, M Pingen, B Haxton, K Mansfield, N Johnson, ... Journal of virology 88 (17), 9553-9567, 2014 | 41 | 2014 |
| Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity M Pingen, AMJ Wensing, K Fransen, A De Bel, D de Jong, ... Retrovirology 11 (1), 1-15, 2014 | 22 | 2014 |
| The atypical chemokine receptor Ackr2 constrains NK cell migratory activity and promotes metastasis CAH Hansell, AR Fraser, AJ Hayes, M Pingen, CL Burt, KM Lee, ... The Journal of Immunology 201 (8), 2510-2519, 2018 | 17 | 2018 |
| Diminished transmission of drug resistant HIV-1 variants with reduced replication capacity in a human transmission model M Pingen, R Sarrami-Forooshani, AMJ Wensing, P van Ham, A Drewniak, ... Retrovirology 11 (1), 1-9, 2014 | 15 | 2014 |
| Deep sequencing does not reveal additional transmitted mutations in patients diagnosed with HIV‐1 variants with single nucleoside reverse transcriptase inhibitor resistance … M Pingen, ME van der Ende, AM Wensing, A el Barzouhi, BB Simen, ... HIV medicine 14 (3), 176-181, 2013 | 13 | 2013 |
| Case report Therapy failure resulting from superinfection by a drug-resistant HIV variant M Pingen, JL Nouwen, JA Sander Dinant, M Mild, J Brodin, BB Simen, ... Antiviral therapy 17, 1621-1625, 2012 | 13 | 2012 |
| Placental chemokine compartmentalisation: A novel mammalian molecular control mechanism KM Lee, GJ Wilson, M Pingen, A Fukuoka, CAH Hansell, R Bartolini, ... PLoS biology 17 (5), e3000287, 2019 | 11 | 2019 |
| Pan-viral protection against arboviruses by activating skin macrophages at the inoculation site SR Bryden, M Pingen, DA Lefteri, J Miltenburg, L Delang, S Jacobs, ... Science translational medicine 12 (527), 2020 | 10 | 2020 |
| Infection with the frequently transmitted HIV-1 M41L variant has no influence on selection of tenofovir resistance M Pingen, M Nijhuis, T Mudrikova, A van Laarhoven, N Langebeek, ... Journal of Antimicrobial Chemotherapy 70 (2), 573-580, 2015 | 10 | 2015 |
| Application of cultured human regulatory T cells requires preclinical in vivo evaluation Y Vercoulen, T Guichelaar, J Meerding, M Emmelot, M Pingen, G Storm, ... Journal of allergy and clinical immunology 129 (3), 852-855. e3, 2012 | 9 | 2012 |
| Evolution and viral characteristics of a long-term circulating resistant HIV-1 strain in a cluster of treatment-naive patients LM Hofstra, M Nijhuis, M Pingen, T Mudrikova, A Riezebos-Brilman, ... Journal of Antimicrobial Chemotherapy 68 (6), 1246-1250, 2013 | 8 | 2013 |
| Telbivudine exerts no antiviral activity against HIV-1 in vitro and in humans NM van Maarseveen, AMJ Wensing, D de Jong, GL Beilhartz, A Obikhod, ... Antiviral therapy 16 (7), 1123, 2011 | 8 | 2011 |
| Chemokine receptors coordinately regulate macrophage dynamics and mammary gland development GJ Wilson, A Fukuoka, SR Love, J Kim, M Pingen, AJ Hayes, GJ Graham Development 147 (12), 2020 | 2 | 2020 |
| Human induced CD4+ CD25+ FOXP3+ regulatory T cells suppress effector immune responses in vitro, but not in vivo Y Vercoulen, T Guichelaar, J Meerding, M Emmelot, M Pingen, ... CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 29 (2), 437-437, 2011 | 2 | 2011 |
| Human induced CD4+ CD25+ FOXP3+ regulatory T cells are suppressive in vitro, but fail to suppress inflammation in vivo Y Vercoulen, T Guichelaar, J Meerding, M Emmelot, M Pingen, ... Annals of the Rheumatic Diseases 70 (Suppl 2), A53-A53, 2011 | 2 | 2011 |
| Single transmitted drug resistance mutations: not always an indicator of transmission of more extensive resistance profiles M Pingen, ME van der Ende, AMJ Wensing, CA Boucher, M Schutten Antivir Ther 15, 2010 | 2 | 2010 |
| A novel antiviral formulation inhibits a range of enveloped viruses NF Fletcher, LW Meredith, EL Tidswell, SR Bryden, D Gonçalves-Carneiro, ... Journal of General Virology 101 (10), 1090-1102, 2020 | 1 | 2020 |
